CVS
CVS (CVS) is a Vietnam-listed company.
Aveluro tracks 2 news items mentioning CVS, where recent coverage skews negative (100% of articles). The most recent catalyst was an earnings miss event — "CVS Securities Posts 17th Straight Quarterly Loss, Accumulated Deficit Tops VND 183.5 Billion". Aveluro's composite model rates CVS 6.2/10 (Neutral), blending news sentiment, price momentum, and fundamentals.
CVS Securities Posts 17th Straight Quarterly Loss, Accumulated Deficit Tops VND 183.5 Billion
Recent developments around CVS include 2 notable classified events. On Oct 22, 2026, an earnings miss was reported: CVS posted a Q3/2026 net loss of about VND 2.6 billion, its 17th consecutive loss-making quarter, lifting accumulated losses to roughly VND 183.5 billion against charter capital of VND 456.75 billion. On Jul 31, 2026, an earnings miss was reported: CVS reported a net loss of 31 billion VND in Q2 2026, its 16th consecutive quarterly loss, lifting accumulated losses to nearly 181 billion VND.
The overall tone of recent coverage is negative, with 2 of 2 events carrying bearish sentiment.
By Aveluro Research Team · Editorial policy · Caveat: Not investment advice. · How Aveluro computed this